Rapport Therapeutics Inc (RAPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 20,800 | 17,094 | 0 | 9,564 | 6,630 |
| Operating Income | -20,800 | -17,094 | N/A | -9,564 | -6,630 |
| Other Income | 2,679 | -5,575 | 0 | 856 | 221 |
| Pre-tax Income | -18,121 | -22,669 | 0 | -8,708 | -6,409 |
| Income Tax | N/A | N/A | N/A | 1 | 2 |
| Net Income Continuous | -18,121 | -22,669 | N/A | -8,709 | -6,411 |
| Net Income | $-18,121 | $-22,669 | $N/A | $-8,709 | $-6,411 |
| EPS Basic Total Ops | -1.70 | -11.07 | N/A | -5.70 | -4.45 |
| EPS Basic Continuous Ops | -1.70 | -11.07 | N/A | -5.70 | -4.45 |
| EPS Diluted Total Ops | -1.70 | -11.07 | N/A | -5.70 | -4.45 |
| EPS Diluted Continuous Ops | -1.70 | -11.07 | N/A | -5.70 | -4.45 |
| EPS Diluted Before Non-Recurring Items | -1.70 | -11.07 | N/A | N/A | N/A |
| EBITDA(a) | $-21,421 | $-17,920 | $N/A | $-9,541 | $-6,630 |